Overview

Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)

Status:
Completed
Trial end date:
2016-03-14
Target enrollment:
Participant gender:
Summary
The objective of the present study is to establish the safety and efficacy of Prochymal® following first acute myocardial infarction.
Phase:
Phase 2
Details
Lead Sponsor:
Mesoblast International Sàrl
Mesoblast, Inc.
Treatments:
Remestemcel-l